+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study

Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study

International Clinical Psychopharmacology 7(3-4): 141-147

One hundred and twenty seven patients with major depressive episode were included in a double-blind, four-week, prospective, randomized, multi-centre parallel-group trial comparing moclobemide and imipramine. The dose of moclobemide was 150-525 mg/day and that of imipramine 50-175 mg/day; the mean daily doses during the last week of treatment were 307 mg and 100 mg of moclobemide and imipramine, respectively. The decrease of the total scores of the Hamilton Depression Scale (HDRS) as well as the Overall Assessment of Efficacy by the Investigators showed significant amelioration of depression in both treatment groups (p < 0.001). No significant differences were found between the moclobemide and imipramine groups with regard to treatment outcome. The onset of the antidepressant activity was faster in the moclobemide group as measured by the Assessment of the Investigators. This difference was not observed when the therapeutic index figures calculated on the basis of the changes in the HDRS scores were scrutinized. Treatment-emergent side effects were somewhat more frequent during imipramine than during moclobemide treatment. Nevertheless, a total of only four patients discontinued the trial prematurely because of poor tolerability. Imipramine-treated patients reported more anticholinergic side effects, whereas tiredness and headache were observed more frequently in the moclobemide-treated patients. Restlessness, nervousness and sleep disturbances were noted with equal incidence in both patient groups.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 046697302

Download citation: RISBibTeXText

PMID: 8468435

Related references

A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients. Acta Psychiatrica Scandinavica 89(6): 382-389, 1994

A randomized, double-blind, multi-centre, parallel-group study comparing the tolerability and efficacy of moclobemide and dothiepin hydrochloride in depressed patients in general practice. International Clinical Psychopharmacology 7(3-4): 159-165, 1993

Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study. Journal of Clinical Psychopharmacology 15(4 Suppl 2): 24s-30s, 1995

Doxepin versus imipramine in psychoneurotic depressed patients with sleep disturbance: a double-blind study. Journal of Clinical Psychiatry 39(12): 852-856, 1978

Onset of action and clinical effectiveness of desmethyl imipramine vs imipramine in a double blind study of depressed patients. Cerletti, A (Editor) Excerpta Medica International Congress Series No 180 The Present Status Of Psychotropic Drugs Xi+ 572p Excerpta Medica Foundation: Amsterdam, Netherlands 522-525, 1969

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. British Journal of Psychiatry 166(6): 712-726, 1995

Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients. International Clinical Psychopharmacology 11(2): 119-127, 1996

A sequential double blind controlled study of moclobemide and mianserin in elderly depressed patients. International Journal of Geriatric Psychiatry 5(3): 199-204, 1990

Amoxapine and imipramine: a double-blind study in depressed patients. Current Therapeutic Research Clinical and Experimental 15(12): 919-922, 1973

Double-blind comparison of moclobemide, imipramine and placebo in depressive patients. Acta Psychiatrica Scandinavica. Supplementum 360: 54-56, 1990

A double-blind comparison study of nomifensine and imipramine in treating depressed patients. Zhonghua Shen Jing Jing Shen Ke Za Zhi 22(2): 73, 1989

A double-blind comparison of moclobemide and amineptine in the treatment of depressed out-patients. Psychopharmacology 106 Suppl: S116-S117, 1992

Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients. L'Encephale 19(4): 333-340, 1993

A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology. 127(3): 231-237, 1996